Detalles de la búsqueda
1.
Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.
J Med Virol
; 89(5): 759-766, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27769099
2.
The phenomenon of released-activity. Reply on comment on Don et al.: Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.
J Med Virol
; 89(7): 1127-1130, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28036118
3.
Activity of ergoferon against lethal influenza A (H3N2) virus infection in mice.
Antivir Ther
; 22(4): 345-351, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27924780
4.
Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results.
Antiviral Res
; 142: 185-192, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28356234
5.
Retraction: Activity of ergoferon against lethal influenza A (H3N2) virus infection in mice.
Antivir Ther
; 24(3): 235, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31348765
6.
Retraction notice to "Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results" [Antiviral Research 142 (2017) 185-192].
Antiviral Res
; 164: 176, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30885298
Resultados
1 -
6
de 6
1
Próxima >
>>